NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment

E. Janevik-Ivanovska; J. Gestin; E. Aneheim; S. Lindegren; J. Gaschet; S. Palm; D. Niculae; P. Bouziotis; M. Pruzynski; P. Kolenc; A. I. Jensen; A. Abrunhosa; L. Navarro; H. Jensen; R. Mikolajczak; M. M. Herth; M. Konijnenberg; F. Guerard

NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment

E. Janevik-Ivanovska, J. Gestin, E. Aneheim, S. Lindegren, J. Gaschet, S. Palm, D. Niculae, P. Bouziotis, M. Pruzynski, P. Kolenc, A. I. Jensen, A. Abrunhosa, L. Navarro, H. Jensen, R. Mikolajczak, M. M. Herth, M. Konijnenberg, F. Guerard

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	50
Issue number	suppl. 1
Pages (from-to)	S825-S825
ISSN	1619-7070
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

OpenUrl availability

Full text

Cite this

Janevik-Ivanovska, E., Gestin, J., Aneheim, E., Lindegren, S., Gaschet, J., Palm, S., Niculae, D., Bouziotis, P., Pruzynski, M., Kolenc, P., Jensen, A. I., Abrunhosa, A., Navarro, L., Jensen, H., Mikolajczak, R., Herth, M. M., Konijnenberg, M., & Guerard, F. (2023). NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment. European Journal of Nuclear Medicine and Molecular Imaging, 50(suppl. 1), S825-S825.

@article{15847f4b868e48ed89afd42c32f75419,

title = "NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment",

author = "E. Janevik-Ivanovska and J. Gestin and E. Aneheim and S. Lindegren and J. Gaschet and S. Palm and D. Niculae and P. Bouziotis and M. Pruzynski and P. Kolenc and Jensen, \{A. I.\} and A. Abrunhosa and L. Navarro and H. Jensen and R. Mikolajczak and Herth, \{M. M.\} and M. Konijnenberg and F. Guerard",

year = "2023",

language = "English",

volume = "50",

pages = "S825--S825",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "suppl. 1",

}

Janevik-Ivanovska, E, Gestin, J, Aneheim, E, Lindegren, S, Gaschet, J, Palm, S, Niculae, D, Bouziotis, P, Pruzynski, M, Kolenc, P, Jensen, AI, Abrunhosa, A, Navarro, L, Jensen, H, Mikolajczak, R, Herth, MM, Konijnenberg, M & Guerard, F 2023, 'NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment', European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. suppl. 1, pp. S825-S825.

TY - ABST

T1 - NOAR COST Action

T2 - Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment

AU - Janevik-Ivanovska, E.

AU - Gestin, J.

AU - Aneheim, E.

AU - Lindegren, S.

AU - Gaschet, J.

AU - Palm, S.

AU - Niculae, D.

AU - Bouziotis, P.

AU - Pruzynski, M.

AU - Kolenc, P.

AU - Jensen, A. I.

AU - Abrunhosa, A.

AU - Navarro, L.

AU - Jensen, H.

AU - Mikolajczak, R.

AU - Herth, M. M.

AU - Konijnenberg, M.

AU - Guerard, F.

PY - 2023

Y1 - 2023

M3 - Conference abstract in journal

SN - 1619-7070

VL - 50

SP - S825-S825

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - suppl. 1

ER -